News & Perspective

Nov 11, 2008

Nov 11, 2008

Firm says 'universal' flu vaccine passed early test

(CIDRAP News) – A vaccine designed to offer protection against many strains of influenza viruses appeared safe in low doses and triggered a satisfactory immune response in a phase 1 clinical trial, the vaccine's developer announced recently.

Dec 03, 2013

Dec 03, 2013

News Scan for Dec 03, 2013

Funds to fight global disease
Flu prediction tool

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»